Complete workflow enabling clinical laboratories to evaluate 94 specimens in under 3 hours, or 382 specimens in under 6.5 hours, with a single Thermo Scientific™ KingFisher™ purification system and Applied Biosystems™ real-time PCR system combination.
Targeted specificity to 100% of currently available complete genomes for SARS-CoV-2.
Assays target spike (S) protein and nucleocapsid (N) protein regions having higher specificity and exhibiting lower risk for mutation.
Applied Biosystems™ COVID-19 Interpretive Software, which automatically converts genetic analysis data into diagnosis, helping reduce risk of user interpretation error.
Six approved specimen types, requiring only 200 to 400 μL of sample: bronchoalveolar lavage (BAL), mid-turbinate swabs, nasal swabs, nasopharyngeal swabs, nasopharyngeal aspirate (nasal aspirate), and oropharyngeal swabs.
The Applied Biosystems™ TaqPath™ COVID-19 CE-IVD RT-PCR kit has obtained CE-IVD marking and the TaqPath COVID-19 Combo Kit has obtained EUA marking.